BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16824187)

  • 1. A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999.
    Heeringa J; Conway DS; van der Kuip DA; Hofman A; Breteler MM; Lip GY; Witteman JC
    J Thromb Haemost; 2006 Sep; 4(9):1944-9. PubMed ID: 16824187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study.
    Conway DS; Heeringa J; Van Der Kuip DA; Chin BS; Hofman A; Witteman JC; Lip GY
    Stroke; 2003 Feb; 34(2):413-7. PubMed ID: 12574552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
    Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
    Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
    Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
    J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation.
    Fu R; Wu S; Wu P; Qiu J
    Europace; 2011 Jan; 13(1):31-6. PubMed ID: 20852292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation.
    Li-Saw-Hee FL; Blann AD; Edmunds E; Gibbs CR; Lip GY
    Clin Cardiol; 2001 May; 24(5):409-14. PubMed ID: 11346250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.
    Li-Saw-Hee FL; Blann AD; Lip GY
    J Am Coll Cardiol; 2000 Jun; 35(7):1926-31. PubMed ID: 10841245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events.
    Meus R; Son M; Sobczyk D; Undas A
    Stroke; 2016 Jul; 47(7):1872-8. PubMed ID: 27301942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation.
    Varughese GI; Patel JV; Tomson J; Lip GY
    Heart; 2007 Apr; 93(4):495-9. PubMed ID: 17005711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.
    Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
    Circulation; 2003 Jul; 107(25):3141-5. PubMed ID: 12796127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation?
    Ancedy Y; Berthelot E; Lang S; Ederhy S; Boyer-Chatenet L; Di Angelantonio E; Soulat-Dufour L; Etienney A; Adavane-Scheublé S; Boccara F; Cohen A
    Arch Cardiovasc Dis; 2018 May; 111(5):357-369. PubMed ID: 29685722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.
    Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
    Circulation; 2002 Oct; 106(15):1962-7. PubMed ID: 12370220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
    Kahn SR; Solymoss S; Flegel KM
    CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty.
    Goldsmith IR; Foo LS; Blann AD; Lip GY
    Clin Cardiol; 2000 Aug; 23(8):587-90. PubMed ID: 10941544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.
    Lip GY; Pearce LA; Chin BS; Conway DS; Hart RG
    Heart; 2005 Jun; 91(6):759-63. PubMed ID: 15894770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.
    Conway DS; Buggins P; Hughes E; Lip GY
    J Am Coll Cardiol; 2004 Jun; 43(11):2075-82. PubMed ID: 15172416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.
    Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY
    Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation.
    Watson T; Arya A; Sulke N; Lip GY
    Chest; 2010 Apr; 137(4):869-76. PubMed ID: 19858230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High von Willebrand factor levels increase the risk of stroke: the Rotterdam study.
    Wieberdink RG; van Schie MC; Koudstaal PJ; Hofman A; Witteman JC; de Maat MP; Leebeek FW; Breteler MM
    Stroke; 2010 Oct; 41(10):2151-6. PubMed ID: 20798373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
    Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY
    Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.